港股异动|方达控股(1521.HK)急涨12%获大行唱好
格隆汇7月4日丨次新股方达控股(1521.HK)午后异动拉升,现大涨11.9%,报3.48港元,暂成交3165万港元,最新总市值69.66亿港元。

高盛发表研究报告称,由于方达控股技术主导的全球优质服务获美国、欧盟及中国监管机构认证,在美国及中国市场有潜在上升空间,首予该股“买入”评级,目标价3.71港元。
方达控股(01521.HK)7月初拟出售非核心业务新泽医药技术45%的股权,集团预期不会因新泽出售事项产生重大收益或亏损。拟将代价所得款项用作一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.